Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura E Benjamin

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Nature Reviews. Cancer|June 5, 2003
Tumorigenesis and the angiogenic switchGabriele Bergers, Laura E Benjamin
Cancer Research|May 23, 2002
Placental growth factor is a survival factor for tumor endothelial cells and macrophagesAvner Adini, Tad Kornaga, Farshid Firoozbakht, et al.
Cancer Research|March 8, 2013
Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapyDamien Gerald, Sudhakar Chintharlapalli, Hellmut G Augustin, et al.
Cancer Research|November 20, 2002
Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albuminHagit Dafni, Tomer Israely, Zaver M Bhujwalla, et al.
Genes & Development|November 5, 2003
RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular developmentIrit Adini, Isaac Rabinovitz, Jing Fang Sun, et al.
Cancer Research|November 18, 2008
Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeabilityQi Xue, Benjamin Hopkins, Carole Perruzzi, et al.
Cancer Biology & Therapy|January 24, 2004
Inhibition of Tie-2 signaling induces endothelial cell apoptosis, decreases Akt signaling, and induces endothelial cell expression of the endogenous anti-angiogenic molecule, thrombospondin-1Qi Niu, Carole Perruzzi, Daniel Voskas, et al.
Plos One|July 5, 2013
Correction: Overexpression of MyrAkt1 in Endothelial Cells Leads to Erythropoietin- and BMP4-Independent Splenic Erythropoiesis in MiceRebekah K O'Donnell, Whitney E Goldstein, Carole Perruzzi, et al.
Cancer Biology & Therapy|July 25, 2003
Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinomaLouis K Sussman, Jan Nalinee Upalakalin, Mark J Roberts, et al.
Plos One|February 6, 2013
Overexpression of MyrAkt1 in endothelial cells leads to erythropoietin- and BMP4-independent splenic erythropoiesis in miceRebekah K O'Donnell, Whitney E Goldstein, Carole Perruzzi, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Nature Reviews. Cancer|June 5, 2003
Tumorigenesis and the angiogenic switchGabriele Bergers, Laura E Benjamin
Cancer Research|May 23, 2002
Placental growth factor is a survival factor for tumor endothelial cells and macrophagesAvner Adini, Tad Kornaga, Farshid Firoozbakht, et al.
Cancer Research|March 8, 2013
Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapyDamien Gerald, Sudhakar Chintharlapalli, Hellmut G Augustin, et al.
Cancer Research|November 20, 2002
Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albuminHagit Dafni, Tomer Israely, Zaver M Bhujwalla, et al.
Genes & Development|November 5, 2003
RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular developmentIrit Adini, Isaac Rabinovitz, Jing Fang Sun, et al.
Cancer Research|November 18, 2008
Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeabilityQi Xue, Benjamin Hopkins, Carole Perruzzi, et al.
Cancer Biology & Therapy|January 24, 2004
Inhibition of Tie-2 signaling induces endothelial cell apoptosis, decreases Akt signaling, and induces endothelial cell expression of the endogenous anti-angiogenic molecule, thrombospondin-1Qi Niu, Carole Perruzzi, Daniel Voskas, et al.
Plos One|July 5, 2013
Correction: Overexpression of MyrAkt1 in Endothelial Cells Leads to Erythropoietin- and BMP4-Independent Splenic Erythropoiesis in MiceRebekah K O'Donnell, Whitney E Goldstein, Carole Perruzzi, et al.
Cancer Biology & Therapy|July 25, 2003
Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinomaLouis K Sussman, Jan Nalinee Upalakalin, Mark J Roberts, et al.
Plos One|February 6, 2013
Overexpression of MyrAkt1 in endothelial cells leads to erythropoietin- and BMP4-independent splenic erythropoiesis in miceRebekah K O'Donnell, Whitney E Goldstein, Carole Perruzzi, et al.
Pageof 5